Sishtla Ramakrishnan

Sishtla Ramakrishnan

Active Director Director DIN 07955919
DIN 07955919 First appointment Oct 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Oct 2017
Shareholding value •••• Premium profile

About Sishtla Ramakrishnan

Data last updated:

Sishtla Ramakrishnan is a Director at Shreegen Pharma Limited (since 2025), Managing Director at Srivar Pharma Private Limited (since 2017) and Designated Partner at Avidia Pharma Labs Llp (since 2025), and holds 3 more current directorships. The companies operate in Pharma and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹11.73 Cr; the largest is Shreegen Pharma Limited at ₹9.20 Cr (FY 2023). Earlier, Sishtla Ramakrishnan was a Director at Syngreen Lifesciences Private Limited (2021–2025).

DIN 07955919
Primary Designation Director
Industry Pharma
First Appointment 05 Oct 2017
Oldest Company Age 20 yrs
Largest company Shreegen Pharma Limited · ₹9.20 Cr (FY 2023)
Combined revenue ₹11.73 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shreegen Pharma Limited U24233TG2012PLC083695
Director01 Aug 20252012₹9.20 Cr (FY 2023)Active
Srivar Pharma Private Limited U24100TG2009PTC064986
Managing Director05 Oct 20172009₹2.53 Cr (FY 2024)Active
Designated Partner27 Nov 20252024Active
Vidur Human Care Private Limited U24304TG2018PTC123108
Director22 Feb 20252018Active
Aalto Biotech Private Limited U21001TS2024PTC184812
Director25 Apr 20242024Active
Hakue Labs Private Limited U73100KA2006PTC039126
Director02 Nov 20172006Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jul 20212021₹10.5 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Srivar Pharma Private Limited
Hakue Labs Private Limited
Shreegen Pharma Limited
Aalto Biotech Private Limited
Premium access

Shareholding and investment profile for Sishtla Ramakrishnan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sishtla Ramakrishnan

Sishtla Ramakrishnan currently holds 6 directorships: Shreegen Pharma Limited (Director, since 01 Aug 2025, revenue ₹9.20 Cr (FY 2023)); Srivar Pharma Private Limited (Managing Director, since 05 Oct 2017, revenue ₹2.53 Cr (FY 2024)); Avidia Pharma Labs Llp (Designated Partner, since 27 Nov 2025); Vidur Human Care Private Limited (Director, since 22 Feb 2025); Aalto Biotech Private Limited (Director, since 25 Apr 2024); and 1 more.

Sishtla Ramakrishnan was first appointed on 05 Oct 2017 as Managing Director at Srivar Pharma Private Limited. The most recent appointment on record is 27 Nov 2025 at Avidia Pharma Labs Llp.

The 2 current companies of Sishtla Ramakrishnan that report revenue have a combined latest revenue of ₹11.73 Cr: Shreegen Pharma Limited ₹9.20 Cr (FY 2023); Srivar Pharma Private Limited ₹2.53 Cr (FY 2024).

Sishtla Ramakrishnan held 1 earlier board appointment: Syngreen Lifesciences Private Limited (Director, 08 Jul 2021 to 21 Aug 2025).

The current boards of Sishtla Ramakrishnan's companies include Chandra Balireddy Kotthapalli (Shreegen Pharma Limited), Kanaka Nallamilli Sundara Reddy (Shreegen Pharma Limited), Rajeev Dinesh Srivastava (Shreegen Pharma Limited), Rama Mangeswar Reddy Bobbiti (Shreegen Pharma Limited), Srinivasa Reddy Daka (Shreegen Pharma Limited), Venkata Suryanarayana Reddy Chilukuri (Shreegen Pharma Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available